Correlation of the ALA-PDT Treatment Efficacy and the HPV Genotype Profile of Genital Warts after Cryotherapy Failure and Podophyllotoxin Therapy in Male Patients
Autor: | Monika Słowińska, Magdalena Ciazynska, Dorota Nowicka, Irena Walecka, Leszek Walczak, Elwira Paluchowska, Witold Owczarek |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Hpv genotypes 030103 biophysics medicine.medical_specialty ALA-PDT medicine.medical_treatment Cryotherapy Photodynamic therapy DNA HPV Gastroenterology General Biochemistry Genetics and Molecular Biology Article Genital warts Correlation 03 medical and health sciences treatment efficacy Internal medicine medicine lcsh:Science Ecology Evolution Behavior and Systematics business.industry Paleontology virus diseases medicine.disease Treatment efficacy 030104 developmental biology Real-time polymerase chain reaction Podophyllotoxin Space and Planetary Science lcsh:Q business real-time PCR medicine.drug genital warts |
Zdroj: | Life Volume 11 Issue 2 Life, Vol 11, Iss 146, p 146 (2021) |
ISSN: | 2075-1729 |
Popis: | Background: Genital warts are the manifestation of the human papillomavirus (HPV) infection, which may last for weeks or months before the clinical presentation. The primary aim of the study was the correlation of the DNA HPV genotypes eradication with the treatment response in male patients with persistent genital warts. Methods: Twenty-one male patients (age range: 22–58) after failure of cryotherapy and podophyllotoxin treatment were enrolled in the study. Genetic tests (Real Time - PCR method) analyzed the presence of DNA-HPV before and 6 months after four sessions (4 weeks apart) of photodynamic therapy with 5-aminolaevulinic acid (ALA-PDT). The treatment efficacy was evaluated before each PDT session and at the end of the study. Results: The single HPV DNA type was present in 15/21 of the patients (13/15 HPV6). The high-risk HPV types were found in 8/21 subjects, of which 6/8 had several types. Six months after four sessions of PDT, complete response was found in 16/21 (76.19% p = 0.0007) of patients, and DNA HPV clearance was found in 66.67% (p = 0.03). The eradication rate differed among patients with primary low-risk and high-risk HPV types—76.92% (10/13 p = 0.0003) and 50% (4/8 p = 0.05) respectively. Conclusion: ALA-PDT is an effective treatment even after the failure of previous modalities. The persistence of clinical lesions and high oncological risk HPV types should be an indication for treatment prolongation. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |